155 related articles for article (PubMed ID: 9279088)
21. [Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines].
Mi Y; Wang L; Bian S
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):627-30. PubMed ID: 11263329
[TBL] [Abstract][Full Text] [Related]
22. The Wilms' tumor suppressor WT1: approaches to gene function.
Menke A; McInnes L; Hastie ND; Schedl A
Kidney Int; 1998 Jun; 53(6):1512-8. PubMed ID: 9607183
[TBL] [Abstract][Full Text] [Related]
23. Coordinate action of Wt1 and a modifier gene supports embryonic survival in the oviduct.
Kreidberg JA; Natoli TA; McGinnis L; Donovan M; Biggers JD; Amstutz A
Mol Reprod Dev; 1999 Apr; 52(4):366-75. PubMed ID: 10092116
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
25. Analysis of possible WT1 RNA processing in primary Wilms tumors.
Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
[TBL] [Abstract][Full Text] [Related]
26. [Genetic diagnosis of leukemia: diagnosis of relapse and complete remission, and prediction of leukemia onset].
Sugiyama H
Rinsho Byori; 2000 Feb; 48(2):155-61. PubMed ID: 10804819
[TBL] [Abstract][Full Text] [Related]
27. Regarding "expression of the Wilms' tumor gene (WT1) in normal hemopoiesis" by P.N. Baird and P.J. Simmons, Experimental Hematology 25:312-320 (1997).
Pritchard-Jones K; Renshaw J
Exp Hematol; 1997 Dec; 25(13):1311-2. PubMed ID: 9406989
[No Abstract] [Full Text] [Related]
28. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
Smith SI; Down M; Boyd AW; Li CL
Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
[TBL] [Abstract][Full Text] [Related]
30. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
[TBL] [Abstract][Full Text] [Related]
32. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S
Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883
[TBL] [Abstract][Full Text] [Related]
34. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
35. Wilms' tumor gene WT1: its oncogenic function and clinical application.
Sugiyama H
Int J Hematol; 2001 Feb; 73(2):177-87. PubMed ID: 11372729
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
37. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
Dehbi M; Hiscott J; Pelletier J
Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
[TBL] [Abstract][Full Text] [Related]
38. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
39. RNA processing. Wilms' tumour--the splicing connection?
Lamond AI
Curr Biol; 1995 Aug; 5(8):862-5. PubMed ID: 7583142
[TBL] [Abstract][Full Text] [Related]
40. Tumour suppressor gene mutations in humans and mice: parallels and contrasts.
Hooper ML
EMBO J; 1998 Dec; 17(23):6783-9. PubMed ID: 9843483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
